KraneShares MSCI All China Health Care Index ETF (KURE) |
| 19.26 0.02 (0.1%) 01-13 15:59 |
| Open: | 19.29 |
| High: | 19.3422 |
| Low: | 19.15 |
| Volume: | 53,831 |
| Market Cap: | 87(M) |
| PE Ratio: | 31.27 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 22.59 |
| Resistance 1: | 19.34 |
| Pivot price: | 18.05 |
| Support 1: | 17.89 |
| Support 2: | 17.00 |
| 52w High: | 21.875 |
| 52w Low: | 13.23 |
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 12 Jan 2026
(KURE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Mon, 01 Dec 2025
Syfe 2025 Thematic Portfolios Reoptimisation: Enhancing China Growth, Tech, ESG, and Healthcare Exposure - Syfe
Thu, 27 Nov 2025
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Mon, 20 Oct 2025
KURE - KraneShares
Mon, 29 Sep 2025
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Fri, 26 Sep 2025
Capitalize on China Healthcare Fundraising With KURE - ETF Database
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
